Insider trade

Director sold ~$1.52M of JAZZ shares in the open market

Traded Aug 3, 2026 · Filed Aug 6, 2026

Why it stands out

A board member of Jazz Pharmaceuticals sold $1.52M of Jazz Pharmaceuticals shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$1M+Pre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$1,517,880

Shares × reported transaction price

Timing vs results

on the day of results (Aug 3, 2026)

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−4.2%	+1.2%	−5.4%
30 days	−6.5%	−0.3%	−6.1%

Past results only. Not a forecast.

This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.